Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.

  title={Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.},
  author={J. Downing and R. Ramasubramanian and R. F. Johnson and B. Minzter and R. Paschall and H. Sundell and Barbara Engelhardt and Richard Lewis},
  journal={Medical hypotheses},
  volume={63 6},
  • J. Downing, R. Ramasubramanian, +5 authors Richard Lewis
  • Published 2004
  • Medicine
  • Medical hypotheses
  • The pathogenesis of preeclampsia stems from aberrant changes at the placental interface. The trophoblastic endovascular invasion of tonic spiral arteries that converts them to passive conduits falters. Uteroplacental insufficiency and fetoplacental hypoxemia result. Secondary maternal oxidative stress and an excessive inflammatory response to pregnancy generate the clinical syndrome of preeclampsia. Current treatment focuses on preventing seizures, controlling hypertension, preserving renal… CONTINUE READING
    Cardiac uses of phosphodiesterase-5 inhibitors.
    • 75
    Effects and mechanisms of action of sildenafil citrate in human chorionic arteries
    • 32
    • PDF
    PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    • 36
    • Highly Influenced
    • PDF


    Publications referenced by this paper.
    Pathogenesis and genetics of pre-eclampsia
    • 1,203
    Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.
    • 584
    • PDF
    Preeclampsia: what we know and what we do not know.
    • 183
    Hypertension, angiotensin II, and oxidative stress.
    • 230
    Interactions Between Nitric Oxide and Lipid Oxidation Pathways: Implications for Vascular Disease
    • 255
    Oxidative stress and altered endothelial cell function in preeclampsia.
    • 156
    Sildenafil ameliorates effects of inhaled nitric oxide withdrawal.
    • 321
    • PDF